ArticleJournal of Alzheimer's disease : JAD2026
Diagnostic value of death certificates for case ascertainment of dementia: A population-based assessment of mortality registry data.
Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundUse of mortality registry data could facilitate dementia case ascertainment in research, but its diagnostic value is uncertain.ObjectiveTo determine the diagnostic value of death certificates for ascertainment of dementia.MethodsWe included 6280 deceased participants of the population-based Rotterdam Study (mean age at death: 83.6 years, 57% women), who had been actively followed during life for the occurrence of dementia through repeated in-person and medical record screening between 1989-2018. We compared lifetime dementia diagnosis to dementia being certified as cause-of-death in the Dutch national mortality registry. We determined concordance of death certificates according to coding method, place of death, and participant characteristics (age at death, dementia duration, and comorbidity). To validate observations, we surveyed 446 certifying physicians.ResultsOverall, 1828 persons (29%) had a diagnosis of dementia during life. Specificity of death certificates for dementia diagnosis consistently exceeded 96%. Sensitivity was below 10% using ICD-9 but increased to about 70% in more recent years using ICD-10. Diagnostic accuracy improved with introduction of ICD-10 (odds ratio [95%CI]: 1.94 [1.08-3.48]), and varied substantially with age at death (OR per decade increase: 0.80 [0.66-0.96]), dementia disease duration (OR [95%CI] for ≥6 years versus 0-2 years: 3.95 [2.56-6.09]), place of death, and comorbidity (OR [95%CI] per additional illness: 0.82 [0.72-0.93]), particularly due to stroke or heart failure. Dementia severity and duration were also reported by physicians as important factors for certifying dementia as a cause of death.ConclusionsDeath certificates have high specificity but limited sensitivity for diagnosis of dementia, in particular in older patients with cardiovascular comorbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.